"If we can attack the disease before those symptoms start, we're doing a major service to the patient and to society." ...

Which is why, in part, the promise — and boom — of blood biomarkers testing has moved quickly in the past three to five years, researchers say. The FDA recently cleared two blood tests that detect ...

New guidelines for blood-based biomarkers, the impact of hormone replacement therapy and risks for cognitive decline with red ...

Alzheimer’s disease blood test developer Quanterix put forward new clinical data from its Simoa assay, which it described as ...

Can driving patterns help predict cognitive decline later in life? A new study finds that certain changes in driving habits ...

Biomarker testing in non-small cell lung cancer is underutilized, hindering optimal treatment. Streamlined processes and ...

A team of researchers has pinpointed two blood biomarkers that are linked to cognitive function changes that can happen to women in midlife. Authors of the study say this could lead to developments ...

In a recent study published in the journal Nature Medicine, researchers in Sweden and the United States assessed whether a brief self-administered digital cognitive battery, alone or combined with a ...

Experts discuss the underutilization of biomarker testing in metastatic lung cancer, emphasizing the need for reflexive ...